Showing results (1-10 of 111) with videos related to
Sort By:
Pageof 12
Cancer Research|August 9, 2003
Transcription factor c-Jun activation represses mdr-1 gene expressionZe-Hong Miao, Jian DingAI Zheng = Aizheng = Chinese Journal of Cancer|August 15, 2003
[Research advances on circumventing tumor multidrug resistance]Ze-Hong Miao, Jian DingMarine Drugs|March 19, 2013
Marine-derived angiogenesis inhibitors for cancer therapyYing-Qing Wang, Ze-Hong MiaoSheng Li Ke Xue Jin Zhan [Progress in Physiology]|February 25, 2005
[The emergent role of p38 MAPKs in the regulation of cell cycle]Yi Chen, Ze-Hong Miao, Jian DingSheng Li Ke Xue Jin Zhan [Progress in Physiology]|February 1, 2008
[Repair pathways in response to DNA double-strand breaks]Min Huang, Ze-Hong Miao, Jian DingActa Pharmacologica Sinica|August 28, 2012
Newly discovered angiogenesis inhibitors and their mechanisms of actionZe-hong Miao, Jian-ming Feng, Jian DingActa Pharmacologica Sinica|August 3, 2010
Poly(ADP-ribose) polymerase inhibitors as promising cancer therapeuticsJin-xue He, Chun-hao Yang, Ze-hong MiaoFEBS Letters|June 21, 2005
The p53 pathway is synergized by p38 MAPK signaling to mediate 11,11'-dideoxyverticillin-induced G2/M arrestYi Chen, Ze-Hong Miao, Wei-Min Zhao, et al.Oncotarget|July 24, 2015
Tanshinone I inhibits tumor angiogenesis by reducing Stat3 phosphorylation at Tyr705 and hypoxia-induced HIF-1α accumulation in both endothelial and tumor cellsYan Wang, Jia-Xin Li, Ying-Qing Wang, et al.Trends in Pharmacological Sciences|May 16, 2006
Emerging cancer therapeutic opportunities target DNA-repair systemsJian Ding, Ze-Hong Miao, Ling-Hua Meng, et al.Pageof 12